The Neurointervention Center

Filter Your Results

 

News

 

DEFUSE 3 Shows Effectiveness of Stroke Thrombectomy to 16 Hours, Utility of Perfusion Imaging

January 24, 2018 -- The National Institutes of Health (NIH) announced that the results of the DEFUSE 3 trial were presented at the International Stroke Conference 2018, held J…

European PROMISE Study of Penumbra System Presented at International Stroke Conference

January 25, 2018 -- Penumbra, Inc. announced results of the company-sponsored PROMISE study, a European registry evaluating the company's Ace reperfusion catheters and dem…

COMPASS Compares Penumbra's Aspiration System to Stent Retrievers in Acute Ischemic Stroke

January 25, 2018 -- Penumbra, Inc. announced the presentation of results from the COMPASS trial, showing that the use of Penumbra's aspiration system was noninferior to st…

ARISE II Results Presented for Cerenovus' Embotrap for Ischemic Stroke

January 25, 2018 -- Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced that data from the ARISE II clinical trial, an analysis of revascularizat…

2018 AHA/ASA Guidelines Support Stroke Systems of Care, Telemedicine, and Expanded Therapy Window

January 24, 2018 -- The American Heart Association/American Stroke Association (AHA/ASA) announced the publication of the 2018 Guidelines for the Early Management of Patients …

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

FDA Clears Medtronic's Riptide Aspiration System for Treatment of Acute Ischemic Stroke

January 16, 2018 -- Medtronic announced that the company’s neurovascular business unit received US Food and Drug Administration clearance for its Riptide aspiration syst…

Cerebrotech's Visor Device Receives FDA Clearance

January 10, 2018 -- Cerebrotech Medical Systems, Inc. recently announced US Food and Drug Administration clearance for the company's Visor device, previously known as the …

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.